These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1788 related items for PubMed ID: 19208365

  • 1. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [Abstract] [Full Text] [Related]

  • 2. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z, Mizuno S, Nakamura T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H, Vohra BP, Zhang Y, Heuckeroth RO.
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
    Liu Z, Sakamoto T, Ezure T, Yokomuro S, Murase N, Michalopoulos G, Demetris AJ.
    Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
    [Abstract] [Full Text] [Related]

  • 5. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N, Nagel M, Straub BK, Wörns MA, Schuchmann M, Galle PR, Schattenberg JM.
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar 01; 314(3):G319-G333. PubMed ID: 29191940
    [Abstract] [Full Text] [Related]

  • 6. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
    Inoue H, Yokoyama F, Kita Y, Yoshiji H, Tsujimoto T, Deguchi A, Nakai S, Morishita A, Uchida N, Masaki T, Watanabe S, Kuriyama S.
    Int J Mol Med; 2006 May 01; 17(5):857-64. PubMed ID: 16596271
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
    Kroy DC, Schumacher F, Ramadori P, Hatting M, Bergheim I, Gassler N, Boekschoten MV, Müller M, Streetz KL, Trautwein C.
    J Hepatol; 2014 Oct 01; 61(4):883-90. PubMed ID: 24845607
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N, Hatano E, Taura K, Tada M, Kodama Y, Nitta T, Iwaisako K, Seo S, Nakajima A, Ikai I, Uemoto S.
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb 01; 294(2):G498-505. PubMed ID: 18174271
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
    Fernández-Martínez E, Pérez-Alvarez V, Tsutsumi V, Shibayama M, Muriel P.
    Exp Toxicol Pathol; 2006 Aug 01; 58(1):49-58. PubMed ID: 16617007
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
    Boost KA, Kim HJ, Engl T, Oppermann E, Jonas D, Oertl A, Blaheta RA.
    Int J Mol Med; 2006 Mar 01; 17(3):475-82. PubMed ID: 16465395
    [Abstract] [Full Text] [Related]

  • 14. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
    Borkham-Kamphorst E, Huss S, Van de Leur E, Haas U, Weiskirchen R.
    Liver Int; 2012 Oct 01; 32(9):1342-53. PubMed ID: 22698069
    [Abstract] [Full Text] [Related]

  • 15. Potent antioxidant role of pirfenidone in experimental cirrhosis.
    Salazar-Montes A, Ruiz-Corro L, López-Reyes A, Castrejón-Gómez E, Armendáriz-Borunda J.
    Eur J Pharmacol; 2008 Oct 24; 595(1-3):69-77. PubMed ID: 18652820
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N, Lüdde T, Assmus U, Roskams T, Vander Borght S, Trautwein C.
    Gastroenterology; 2007 Jun 24; 132(7):2504-17. PubMed ID: 17570222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
    Wang H, Zhang Y, Heuckeroth RO.
    Hepatology; 2007 Jun 24; 45(6):1527-37. PubMed ID: 17538930
    [Abstract] [Full Text] [Related]

  • 19. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
    Moransard M, Sawitzky M, Fontana A, Suter T.
    Glia; 2010 Apr 24; 58(5):559-71. PubMed ID: 19941340
    [Abstract] [Full Text] [Related]

  • 20. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.
    Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ.
    Hepatology; 2003 Nov 24; 38(5):1188-98. PubMed ID: 14578857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 90.